Index by author

October 01, 2008; Volume 75,Issue 10

A

  1. Asudani, Deepak

    1. A judgment call
      Deepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;

      A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?

B

  1. Bain, Mark

    1. Which patients benefit from carotid stenting? What recent trials show
      Mark Bain, MD, Asma M. Moheet, MD and Peter Rasmussen, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 714-720;

      Whether carotid stenting has any advantage over carotid surgery and which patients should undergo it are still topics of study and debate.

E

  1. Eyre, David R.

    1. Using biochemical markers of bone turnover in clinical practice
      Using biochemical markers of bone turnover in clinical practice
      Frederick R. Singer, MD and David R. Eyre, PhD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 739-750;

      Although no guidelines to date recommend the widespread use of these markers in clinical practice, we believe they will eventually be accepted.

H

  1. Hirsch, Sheldon

    1. An update on proteinuric chronic kidney disease: The dual-goal approach
      Sheldon Hirsch, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 705-713;

      To slow the progression of proteinuric chronic kidney disease, we may need to set goals for lowering both blood pressure and urinary albumin excretion, using drugs that block the renin-angiotensin-aldosterone system at multiple sites or in higher doses. However, this dual-goal approach needs to be validated prospectively.

  2. Hoogwerf, Byron J.

    1. A Clinician and Clinical Trialist’s Perspective
      Byron J. Hoogwerf, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 729-737;

      Even though more people died in the intensive-treatment group than in the standard-treatment group, the results from this trial should not substantially alter our usual approach to glucose-lowering.

K

  1. Kim, Chin Hee

    1. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
      Chin Hee Kim, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 721-728;

      As we get heavier, our livers get fattier. Despite an explosion of research on nonalcoholic fatty liver disease and gains in understanding its epidemiology and pathogenesis, a number of issues remain unresolved, including how to treat it.

L

  1. Licata, Angelo A.

    1. Biochemical markers of bone turnover: Useful but underused
      Angelo A. Licata, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 751-752;

      Markers tell us the risk of fracture and are useful in patient management. But will insurance pay for testing?

M

  1. Mandell, Brian F.

    1. When a quick sound bite won’t do
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 686;

      In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, why did more patients die if they got intensive therapy than if they got standard therapy? In this issue of the Journal, an investigator in this trial gives his analysis.

  2. Moheet, Asma M.

    1. Which patients benefit from carotid stenting? What recent trials show
      Mark Bain, MD, Asma M. Moheet, MD and Peter Rasmussen, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 714-720;

      Whether carotid stenting has any advantage over carotid surgery and which patients should undergo it are still topics of study and debate.

P

  1. Patel, Ruchita

    1. A judgment call
      Deepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;

      A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?

R

  1. Rasmussen, Peter

    1. Which patients benefit from carotid stenting? What recent trials show
      Mark Bain, MD, Asma M. Moheet, MD and Peter Rasmussen, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 714-720;

      Whether carotid stenting has any advantage over carotid surgery and which patients should undergo it are still topics of study and debate.

S

  1. Schreiber, Martin J.

    1. Preventing renal disease progression: Can complete renin-angiotensin- aldosterone blockade work?
      Martin J. Schreiber, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 699-704;

      In view of the risks of complete blockade of the renin-angiotensin- aldosterone pathway, more data from clinical trials are needed before the general medical community widely applies this strategy to prevent progressive chronic kidney disease.

  2. Singer, Frederick R.

    1. Using biochemical markers of bone turnover in clinical practice
      Using biochemical markers of bone turnover in clinical practice
      Frederick R. Singer, MD and David R. Eyre, PhD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 739-750;

      Although no guidelines to date recommend the widespread use of these markers in clinical practice, we believe they will eventually be accepted.

  3. Stayman, Aaron

    1. A judgment call
      Deepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;

      A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?

W

  1. Wretzel, Sharon

    1. A judgment call
      Deepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MD
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;

      A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?

Y

  1. Younossi, Zobair M.

    1. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
      Chin Hee Kim, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine October 2008, 75 (10) 721-728;

      As we get heavier, our livers get fattier. Despite an explosion of research on nonalcoholic fatty liver disease and gains in understanding its epidemiology and pathogenesis, a number of issues remain unresolved, including how to treat it.

Back to top

In this issue